Skip to content
‹ Back to IndustriesHealthcare

AI Looks to Add the Value in Value-Based Care in 2024

Healthcare providers are increasingly turning to AI to realize the financial and clinical potential of value-based care models. AI tools are being deployed to improve patient outcomes, reduce costs, and streamline care coordination in ways that traditional fee-for-service models have not incentivized. The 2024 outlook sees AI as a key enabler in closing the gap between value-based care's promise and its real-world execution.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Experts Talk on MarketScale.

By David Kemp · · Ai in Value-based CareBrian UrbanDavid KempDr. Jose Medina-inojosa
Share

Key takeaways

01

AI is emerging as a critical tool for helping healthcare providers meet value-based care performance metrics.

02

Clinical and financial outcomes stand to improve as AI enhances care coordination, risk stratification, and predictive analytics.

03

2024 is positioned as a pivotal year for AI adoption within value-based care frameworks.

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

The healthcare landscape is transforming, with artificial intelligence (AI) playing a pivotal role in advancing value-based care in 2024. Precision medicine, a cornerstone of VBC (value-based care), is being scaled up through innovative technologies, enabling healthcare delivery organizations to provide more individualized care by analyzing detailed aspects of a person’s health and environment. Despite the growing trends in AI and VBC, challenges such as scalability and large-scale adoption remain, highlighting the need for more robust data management systems and predictive analytics. Guidehealth are making significant strides, acquiring divisions like Arcadia’s value-based care service to enhance predictive and generative AI technologies, aiming to improve provider performance in risk-based contracts. As the healthcare industry navigates the post-Covid-19 landscape, AI's responsible and augmented use in clinical decision-making and patient care prioritization is becoming increasingly crucial.

How can AI effectively support the transition to and optimization of value-based care in 2024?

The recent Experts Talk roundtable, hosted by David Kemp, MarketScale Healthcare Lead, tackles this critical subject. The discussion featuring Shawn Nason, the Founder & Chief Experience Officer at MOFI; Dr. José Medina-Inojosa, an Assistant Professor of Epidemiology at the Mayo Clinic College of Medicine; Dr. Michal Tzuchman Katz, a Pediatrician & CEO/Co-founder of Kahun; and Brian Urban, the Director of Innovation & Emerging Markets, at FinThrive, explores the current state and future trajectory of AI in enhancing healthcare outcomes and efficiency.

In this session, the panel covers the following:

  • Progress in Adopting Value-Based Care Models, including the evolution from traditional fee-for-service to value-based care contracts
  • AI's Role in Enhancing Patient Care with a focus on how AI can aid in predictive care models, especially for patients with chronic conditions, and its potential to reduce administrative burdens on healthcare providers
  • Challenges and Opportunities in implementing AI in healthcare, including issues of trust, data management, and the need for a holistic approach that includes social determinants of health

Shawn Nason is a transformative figure in healthcare innovation, renowned for his disruptive thinking and approach to healthcare transformation. His expertise radically rethinks how healthcare organizations can create a more patient-centric experience. Nason's healthcare and customer experience background, including his tenure at the Walt Disney Company, has equipped him with unique insights into how industries can intersect to enhance patient engagement and satisfaction.

Dr. José Medina-Inojosa is a distinguished figure in epidemiology and public health. His work at the Mayo Clinic College of Medicine has been instrumental in advancing our understanding of the interplay between lifestyle factors and chronic diseases. With a focus on preventive medicine, Dr. Medina-Inojosa has contributed significantly to research on cardiovascular health and obesity, emphasizing the importance of holistic approaches in patient care.

Dr. Michal Tzuchman Katz brings a unique perspective to integrating AI in healthcare as a pediatrician and a leader in healthcare technology. Her work focuses on leveraging technology to enhance clinical decision-making and patient care. Dr. Katz's expertise bridges the gap between clinical practice and technological innovation, ensuring that patient care remains at the forefront of healthcare advancements.

Brian Urban is a visionary in healthcare finance and innovation. His role at FinThrive has positioned him at the forefront of exploring emerging markets and innovative solutions in healthcare. Urban's insights into the financial aspects of healthcare, combined with his focus on innovation, make him an essential voice in discussions about the future of healthcare, especially in the context of value-based care and technological integration.

Experts Talk

Part of this channel

Experts Talk

Industry experts debate the ideas that drive B2B decisions.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

David Kemp
David KempHealthcare Lead, Highway to Health

With experience in coaching college basketball, supporting large healthcare systems through ICD-10, to now leading the healthcare vertical at MarketScale, David enjoys the journey. Craving knowledge is one of David's core values, and he has the opportunity to learn from some of the best as host of the Highway to Health podcast series.

B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Zoom's stake in Medaica aims to bring the physical exam into video visits

Zoom Ventures made an undisclosed strategic investment in Medaica, whose FDA-cleared M1 telehealth stethoscope supports real-time remote heart and lung auscultation. Zoom already integrates with EHRs including Epic, Oracle Cerner Millennium and Athenahealth, but an investment is not an integration and no combined product has been announced. Cardiology follow-ups and care facilities are highlighted as likely early use cases.

  • 01Video gave telehealth the patient's face; an FDA-cleared remote stethoscope adds the heartbeat, and Zoom now has a financial stake in that second layer.
  • 02Today's cleared capability is real-time heart and lung auscultation; the wider mix of third-party devices, AI analysis and decision support is still in development.
  • 03For health systems with elderly or rural cardiology panels, the sharper vendor question is how exam findings reach the EHR record of the visit.

Nov 21, 2026

How Memorial Hermann measured $37,500 in AI scribe value per ER doctor

How Memorial Hermann measured $37,500 in AI scribe value per ER doctor

Memorial Hermann emergency physicians using Ambience Healthcare's AI documentation generated about $37,500 more in yearly productivity value than non-users. That figure is gross and comparative. It comes from billing data annualized over 160 shifts and excludes software costs, so buyers must build the cost side themselves.

  • 01Memorial Hermann's $37,500 per emergency physician is gross: the gap in work RVUs per clinical hour between AI documentation users and non-users, annualized over 160 ten-hour shifts, before any software or implementation cost.
  • 02Divided out, that gain comes to roughly $234 a shift or about $23 per clinical hour, a practical yardstick to hold against any all-in per-physician cost quote.
  • 03When a vendor puts fees at risk against outcomes, the comparison group, billing source and acuity adjustment become contract terms, because they decide what counts as a gain worth paying for.

Nov 21, 2026

Capsa's RoboPharma HV Wall is the first central fill system confirmed compatible with Parcel Health's paper vials

Capsa's RoboPharma HV Wall is the first central fill system confirmed compatible with Parcel Health's paper vials

Capsa Healthcare says its RoboPharma HV Wall is the first central fill automation system confirmed to fill Parcel Health’s Tully Tube, a paper prescription vial. The confirmation matters because central fill and mail order sites can only use containers their machines can handle—but this applies to the HV Wall specifically and is not a named production deployment. Buyers can see the vials at ASHP Midyear, Dec. 6–9.

  • 01A central fill site can't switch to a paper vial its automation can't handle. Confirmed machine compatibility is the gate, and the RoboPharma HV Wall is the first system through it for the Tully Tube.
  • 02The up to 71 percent plastic reduction per unit is a ceiling measured against a similar-size plastic vial, so operators modeling sustainability targets should ask for the comparison basis for their own vial sizes.

Nov 20, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Experts

David Kemp
David Kemp

Host, Experts Talk

Highway to Health

David Kemp is a host and content producer at MarketScale, where he leads the Experts Talk series covering emerging trends across healthcare and other industries. He focuses on distilling expert perspectives into accessible analysis for B2B audiences. His work spans interviews, editorial segments, and industry roundups.

Brian Urban
Brian Urban

Healthcare innovation · Healthcare Rethink host

Duo Health

Brian Urban works at Duo Health. His MarketScale recordings feature his earlier FinThrive work as host of Healthcare Rethink and as a guest discussing health data, access and care delivery. Brian often asks for the story before the job title. Introducing his interview with Shawn Nason, he asks to go back before Mofi, before the board roles and even before Disney. That opening gives the guest room to explain how earlier experiences shaped the work. In his own personal conversation, Brian describes a day bookended by his children and animals: feeding dogs, ducks and chickens at six in the morning, then settling everyone again at night. His guest list also follows the people connecting health research with organizational decisions. Claire Manneh brings provider research and data tokenization to the discussion; Sameer Kokan explains the business and accountability work behind health-equity initiatives at Point32Health. Their career paths are part of the interviews alongside the technical and organizational questions.

DJ
Dr. José Medina-Inojosa

Cardiovascular disease fellow

Emory University School of Medicine

Dr. José Medina-Inojosa is a cardiovascular disease fellow at Emory University School of Medicine. His earlier work at Mayo Clinic included research on central obesity and cardiovascular risk. In his MarketScale conversations, he returns to practical questions: can a patient reach the clinician, obtain the prescription and understand why a recommendation matters? He co-hosted Health Matters with Alisa Johnsrud in 2021, bringing clinicians into conversations about prevention, health equity and public-health information. His later contributions explore virtual assessments, remote specialist collaboration and the transition to value-based care. In a discussion of body-volume assessment, he put the hoped-for benefit of technology in personal terms: less workload for practitioners and more useful face-to-face interaction with patients.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512